Toll-like receptor signaling pathways - Therapeutic opportunities

Chandra Mohan, Jiankun Zhu

Research output: Contribution to journalReview articlepeer-review

134 Scopus citations


Toll-like receptors (TLRs) are transmembrane proteins acting mainly as sensors of microbial components. Triggering TLRs results in increased expression of multiple inflammatory genes, which then play a protective role against infection. However, aberrant activation of TLR signaling has a significant impact on the onset of cancer, allergy, sepsis and autoimmunity. Various adaptor proteins, including MyD88, IRAKs, TIRAP, TRIF, and TRAM, are involved in specific TLR signaling pathways. This article reviews the role of these molecules in TLR signaling, and discusses the impact of this pathway on various disease scenarios. Given their important role in infectious and non-infectious disease settings, TLRs and their signaling pathways emerge as attractive targets for therapeutics.

Original languageEnglish (US)
Article number781235
JournalMediators of Inflammation
StatePublished - 2010

ASJC Scopus subject areas

  • Immunology
  • Cell Biology


Dive into the research topics of 'Toll-like receptor signaling pathways - Therapeutic opportunities'. Together they form a unique fingerprint.

Cite this